What Is DeSci: Challenges and Market Perceptions

Welcome to Decentralized Science (DeSci) — a new framework reimagining how research is funded, shared, and rewarded. The Coalition for Decentralized Healthcare and Life Sciences (CDHLS) brought together three pioneers at the intersection of science, technology, and decentralized technology for a candid conversation about where DeSci stands today, the challenges it faces, and what needs to change for mainstream adoption. Meet The Panel Jelani Clarke, Executive Lead at DeSci World, and Sales & Marketing Head at AminoChain Filippo Frangioni, Product Manager at Novo Nordisk, and Head of Partnerships at Nordic Blockchain Jim Nasr, CEO, Acoer Themes tackled include: The perception problem: Why does DeSci still sound like sci-fi to most scientists? Funding friction: Can decentralized models compete with traditional grants and venture capital? Data ownership: Who really owns research data, and how can blockchain change that? Regulatory roadblocks: What happens when innovation moves faster than policy? Real world implementation: Beyond the hype, where is DeSci actually working today? From pharmaceutical giants to grassroots research collectives, these leaders shared unfiltered insights on what's holding DeSci back—and what could accelerate its adoption. Intrigued? This conversation is the first in a new podcast series launching in 2026 that will dive deeper into the decentralized science revolution. We'll explore: Case studies of successful DeSci projects Interviews with researchers and policy makers Delve into tokenomics, DAOs, and data sovereignty The intersection of AI, biotech, and decentralized systems The future of science is being built by innovators, technologists, and researchers willing to challenge the status quo. Ready to learn more?Watch the full panel discussion or download it at your leisure. Learn about CDHLS here.